Creative Planning
VIVE

Creative Planning’s VIVEVE MED INC VIVE Stock Holding History

Creative Planning’s Portfolio VIVE Stock Details VIVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2
Closed -$15K – 3981
2017
Q2 		$15K Buy
+2
New +$14.9K ﹤0.01% 3380
2016
Q4 		– Hold
0
– – – 4914
2016
Q3 		– Hold
0
– – – 4790
2016
Q2 		– Hold
0
– – – 4575

Other funds holding VIVE

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IG
ING Group Amsterdam, Netherlands $16.4B AUM 34.6% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return

Creative Planning's VIVE Position: Q3 2017 in Review

Creative Planning sold out of VIVEVE MED INC (VIVE) in Q3 2017, closing a stake of 2 shares — an estimated $15K sold.

Creative Planning first reported a position in VIVE in Q2 2017 and held it in 1 quarter. The position peaked at $15K in Q2 2017. 48 funds tracked by Wall St. Rank hold VIVE as of Q3 2017.

  • Creative Planning reported no remaining VIVEVE MED INC position as of Q3 2017 after selling out during the quarter.
  • Creative Planning sold 2 VIVEVE MED INC shares in Q3 2017, an estimated $15K.
  • Creative Planning first reported a position in VIVEVE MED INC in Q2 2017 and held it in 1 quarter.
  • Creative Planning's VIVEVE MED INC position peaked at $15K in Q2 2017.
  • 48 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.